Spaulding Clinical Phase I Clinical Services
When You Need First-Class Service, Think Spaulding First.
Spaulding Clinical is the industry leader in phase-I-focused pharma and biotech clinical trial services. As the phase I industry leader, you can be certain you’re getting our full attention.
Our Phase I subject matter experts are the most knowledgeable in the industry and are fully immersed in the challenges and finer nuances of Phase I trials. Their experience and expertise allow them to see and address potential pitfalls and mitigate risks well before they’ve impacted your trial — while keeping you on time and on budget — guaranteed.
We offer Full-service Phase 1 services
- Cardiac safety studies: World’s largest telemetry site with 96 telemetry beds
- Single ascending dose (SAD)/ multiple ascending dose (MAD)
- Drug-drug interaction
- Pharmacokinetics (PK)
- Pharmacodynamics (PD)
- Food Effect
- First-in-human (FIH)
- Dose selection/optimization
- Maximal Usage Trials (MUsT)
- Critical care
- Immunology and rheumatology
- Infectious diseases
- Metabolic and endocrine
- Nephrology and renal disease
- Rare disease
- Women’s health
Spaulding Clinical’s pharmacology services result in reduced timelines, lower costs, and enhanced decision-making through leading technology in clinical research.
– Project Management
– Clinical Monitoring
– Medical Monitoring
Spaulding Clinical puts clinical trial study participants first. With a low staff/participant ratio, custom-designed facility for cardiac safety, and enhanced data collection processes, Spaulding Clinical’s facility sets the standard for a clinical pharmacology unit.Recruitment and Facility
Data Management and Biometrics
Our clinical and biometric data management process provides timely and accurate results so you get higher quality data sooner.Data Management and Biometrics
Cardiac Safety Solutions
With Spaulding Cardiac Solutions, you benefit from an industry-leading team of experts, including world-renowned cardiologists, that works closely with you to identify cardiac risk early in the drug development process.Cardiac Safety Solutions